Fig. 3From: Development of a hexavalent recombinant protein vaccine adjuvanted with Montanide ISA 50 V and determination of its protective efficacy against acute toxoplasmosisa SDS-PAGE and b Western blot showing the purified 6 vaccine candidates. Lane 1: rH2 (~ 26.7 kDa); Lane 2: rA4 (~ 33.9 kDa); Lane 3: rE4 (~ 38.8 kDa); Lane 4: rD6 (~ 78.1 kDa); Lane 5: rE6 (~ 81.2 kDa); Lane 6: rH6 (~ 110.2 kDa). Arrowheads show the recombinant proteinsBack to article page